Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720915 · ClinicalTrials.gov registry record · NA
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
A NA study of Pulmonary Embolism and Deep Vein Thrombosis, sponsored by McMaster University.
- Completed
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 13
- Study locations
NCT00720915: Completed NA study of Pulmonary Embolism and Deep Vein Thrombosis, sponsored by McMaster University.
NCT00720915 is a NA study of Pulmonary Embolism and Deep Vein Thrombosis that has completed, run by McMaster University. The registered enrollment target is 410 participants, below the 3,050-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (87% lower). The trial reports 13 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720915, a NA study of Pulmonary Embolism and Deep Vein Thrombosis, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.
Conditions Studied
Interventions
- OTHER Discontinue anticoagulant therapy (Negative d-dimer)
- OTHER Continue on anticoagulant therapy (positive d-dimer)
Study Locations (13)
Ontario
- Hamilton General Hospital - Hamilton
- McMaster University - Hamilton
- St. Joseph's Health Care Centre - Hamilton
- Henderson Hospital - Hamilton
Massachusetts
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Centre - Boston
Other
- Limerick, Mid Western Regional Hospital - Limerick
- Addenbrooke's Hospital - Cambridge
District of Columbia
- Lombardi Cancer Center - Washington D.C.
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Michigan
- Henry Ford Hospital - Detroit
North Carolina
- UNC Thrombophilia Program - Chapel Hill
Utah
- Intermountain Medical Centre - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2008-09 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT00720915 record still lists
NCT00720915 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 3,050-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Discontinue anticoagulant therapy (Negative d-dimer) is the first listed.
NCT00720915 lists 13 locations in 8 states (Ontario, Massachusetts, Other).
Frequently Asked Questions
What is clinical trial NCT00720915 about?
NCT00720915 is a clinical study titled "D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months". The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negati...
What is the current status of trial NCT00720915?
This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2008-09. Estimated completion is 2016-12.
What conditions does trial NCT00720915 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Deep Vein Thrombosis.
What interventions are being tested in trial NCT00720915?
The interventions under investigation include: Discontinue anticoagulant therapy (Negative d-dimer) (OTHER), Continue on anticoagulant therapy (positive d-dimer) (OTHER).
Who is sponsoring clinical trial NCT00720915?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00720915 being conducted?
This trial has 13 study locations across District of Columbia, Iowa, Massachusetts, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00720915's enrollment target sits among peer trials
410 15th of 48 higher than 34 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia